Holders over time
- HIMS
- ELV
| Quarter | HIMS | ELV |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 30 holders, $15.0bn |
| Q4 2020 | none listed holders, n.a. | 29 holders, $16.7bn |
| Q1 2021 | 3 holders, $73m | 25 holders, $18.6bn |
| Q2 2021 | 2 holders, $60m | 30 holders, $19.4bn |
| Q3 2021 | 1 holders, $28m | 26 holders, $18.5bn |
| Q4 2021 | 1 holders, $25m | 29 holders, $23.3bn |
| Q1 2022 | 1 holders, $17m | 31 holders, $23.9bn |
| Q2 2022 | 1 holders, $15m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $21m | 34 holders, $22.6bn |
| Q4 2022 | 3 holders, $51m | 34 holders, $25.5bn |
| Q1 2023 | 7 holders, $91m | 39 holders, $22.5bn |
| Q2 2023 | 5 holders, $86m | 38 holders, $20.6bn |
| Q3 2023 | 4 holders, $56m | 34 holders, $19.8bn |
| Q4 2023 | 4 holders, $64m | 36 holders, $20.3bn |
| Q1 2024 | 8 holders, $242m | 35 holders, $21.3bn |
| Q2 2024 | 11 holders, $344m | 33 holders, $22.1bn |
| Q3 2024 | 13 holders, $313m | 30 holders, $20.2bn |
| Q4 2024 | 10 holders, $628m | 32 holders, $15.9bn |
| Q1 2025 | 8 holders, $738m | 28 holders, $17.1bn |
| Q2 2025 | 9 holders, $1.9bn | 27 holders, $14.8bn |
| Q3 2025 | 9 holders, $2.5bn | 27 holders, $12.7bn |
| Q4 2025 | 4 holders, $740m | 25 holders, $17.0bn |
| Q1 2026 | 6 holders, $68m | 26 holders, $13.6bn |
| Q2 2026 | 4 holders, $183m | 28 holders, $17.7bn |
Hims & Hers Health Inc
- Holders
- 11
- Reported value
- $344m
- Buyers
- 7
- Sellers
- 3
Breadth +4 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (6)
Bridgewater Associates LP, Man Group PLC, Marshall Wace LLP, Two Sigma Investments LP, Voloridge Investment Management LLC, Winton Group Ltd
Only HIMS (5)
Farallon Capital Management LLC, Oaktree Capital Management LP, Renaissance Technologies LLC, Tudor Investment Corp, Verition Fund Management LLC
Only ELV (27)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Point72 Asset Management LP, Ruane Cunniff & Goldfarb LP, and 2 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.